Pharmaceutical Supply – Adenosine Injection

The contract involves the supply and delivery of FDA-compliant Adenosine Injection designated by NSN 6505016660343 and NDC NDC25021-0301-68, specifically for use in emergency cardiac care scenarios. All products must meet stringent regulatory standards and include proper packaging and labeling as required for military medical use. Delivery is structured under FOB Destination terms, ensuring the shipment arrives directly at Joint Base Elmendorf-Richardson in Alaska, with responsibility for transport and handling resting with the supplier until receipt by the designated military location. The contract is classified as a subcontract under the Department of Defense, managed by the Defense Logistics Agency, and falls under the NAICS code 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on July 21, 2026, and is tied to the award reference SPE2DX25D9900 with delivery contract SPE2DP26F7881, indicating an active procurement process for critical medical supplies within the defense healthcare system.